Background
==========

*Shigella*is the primary pathogen causing bacillary dysentery in developing countries. There are an estimated 164.7 million people worldwide infected by *Shigella*annually; resulting in 1.1 million deaths, most being children under five years \[[@B1]\]. A more recent study estimated approximately 125 million annual shigellosis cases and 14,000 related deaths in Asia \[[@B2]\], suggesting that the death rate has decreased significantly in recent years. Among the four *Shigella*species, *S. dysenteriae*, *S. flexneri*, *S. boydii*, and *S. sonnei*, *S. flexneri*is the predominant species \[[@B3]\].

*S. flexneri*serotyping are based on structure of the O-antigen lipopolysaccharide. There are 15 known serotypes: 1a, 1b, 1c, 2a, 2b, 3a, 3b, 4a, 4b, 5a, 5b, 6, X, Xv and Y \[[@B4],[@B5]\]. Except for serotype 6, all share a common tetrasaccharide backbone of repeating units of *N*-acetylglucosamine-rhamnose-rhamnose-rhamnose \[[@B6]\]. By adding glucosyl and/or *O*-acetyl groups to one or more of the sugars on the tetrasaccharide unit, various serotypes are formed. Serotype Y possesses the primary basic O-antigen without any modification of the tetrasaccharide backbone \[[@B6]\].

It is well known that *S. flexneri*serotype conversion is mediated by temperate bacteriophages \[[@B6],[@B7]\]. Six different serotype-converting phages or prophages, SfI, SfII, Sf6, SfIV, SfV and SfX, have been identified and characterized \[[@B8]-[@B12]\], which can convert serotype Y to serotype 1a, 2a, 3b, 4a, 5a and X respectively \[[@B8]-[@B12]\]. Except for Sf6 which carries a single gene, *oac*, for acetylation of the O-antigen \[[@B13]\], the other phages carry three genes, *gtrA*, *gtrB*, and *gtr*~type~for O-antigen modification. The first two *gtr*genes are highly conserved and interchangeable in function, while the third *gtr*gene encodes a type-specific glucosyltransferase responsible for the addition of glucosyl molecules to sugar residue(s) on the basic O-antigen repeating unit \[[@B9],[@B12],[@B14]\]. These phages integrate into the *S. flexneri*host chromosome either at *tRNA-thrW*downstream of *proA*\[[@B15]\] or at *tRNA-argW*adjacent to *yfdC*\[[@B11]\]. Once integrated, the *int*and O-antigen modification genes are located at the opposition ends of the prophage genome, flanked by an *attL*sequence on the left and an *attR*sequence on the right \[[@B15]\].

Recently, untypeable or novel serotypes of *S. flexneri*from natural infections had been reported worldwide \[[@B5],[@B16],[@B17]\]. A novel serotype 1c was identified in Bangladesh in the late 1980s and was a predominant serotype in Vietnam and other Asian countries \[[@B16],[@B17]\]. Serotype 1c was a result of modification of serotype 1a with addition of a glucosyl group by a cryptic prophage carrying a *gtr1C*gene cluster \[[@B18]\]. More recently, a new serotype named as Xv emerged in China, and replaced 2a to become the most prevalent *S. flexneri*serotype \[[@B5]\]. Although the antigenic determinant for the v variant is not yet known, the phage SfX, which is responsible for the group 7;8 antigenic determinant, was inducible from the sequenced *S. flexneri*Xv strain 2002017 \[[@B5]\]. Therefore emergence and spread of novel *S. flexneri*serotypes in nature poses a significant public health threat globally and in particular in developing countries where *S. flexneri*is the predominant cause of shigellosis.

In order to reveal possible roles played by the serotype-converting phages in the emergence of new serotypes, and potential of emergence of novel serotypes through this mechanism in nature, we performed infection assays using SfI and SfX, the 2 most common serotype-converting bacteriophages carried by *S. flexneri*based on serotype frequency data \[[@B5],[@B19]\]. We demonstrate that a novel serotype, named serotype 1 d was created in laboratory by infecting *S. flexneri*serotype X strains with a SfI phage or by sequential infection of serotype Y strain with SfX and SfI.

Results and discussion
======================

Creation of a new serotype, serotype 1 d, through serotype conversion with phages SfI and SfX
---------------------------------------------------------------------------------------------

Using the procedures described by Mavris et al. \[[@B12]\], 2 serotype-converting phages, SfI and SfX, were induced and isolated from *S. flexneri*serotype 1a strain 019 and serotype Xv strain 2002017 respectively. The 2 phages were then used to sequentially infect a serotype Y strain 036 in different order.

We first performed sequential infection in the order of SfI and SfX. By infection with SfI, the *S. flexneri*serotype Y strain 036 was converted into serotype 1a (036_1a), which agglutinated with both diagnostic typing sera I and grouping sera 3;4 (also known as Y-5) as shown in Table [1](#T1){ref-type="table"}. Strain 036_1a was then used for infection by SfX, but surprisingly, no plaques appeared, indicating the strain cannot be infected by SfX.

###### 

Serological characterization of *S. flexneri*serotype Y, X, 1a, 1b and 1c using serotyping monoclonal antibodies (MASF)

  Serotypes   Reaction with MASF                                                
  ----------- -------------------- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----
  Fy          \-                   \-   \-   \-   \-   \+   \+   \-   \-   \-   \-
                                                                                
  Fx          \-                   \-   \-   \-   \-   \+   \-   \-   \+   \-   \-
                                                                                
  F1a         \+                   \-   \-   \-   \-   \+   \+   \-   \-   \-   \-
                                                                                
  F1b         \+                   \-   \-   \-   \-   \+   \-   \+   \-   \-   \-
                                                                                
  F1c         \-                   \-   \-   \-   \-   \+   \-   \-   \-   \-   \+
                                                                                
  F1d         \+                   \-   \-   \-   \-   \+   \-   \-   \+   \-   \-

\*Y-5 is a synonym of grouping 3;4 antisera

Next we performed infection in the order of SfX and SfI. The *S. flexneri*serotype Y strain 036 was converted to serotype X by phage SfX infection, which agglutinated only with serotype X-specific grouping sera 7;8. We named this strain as *S. flexneri*036_X (Figure [1A](#F1){ref-type="fig"} and [1B](#F1){ref-type="fig"}). When 036_X was further infected with phage SfI, it was converted to a new serotype, which agglutinated with both of the diagnostic serotype 1a-specific typing sera I and serotype X-specific grouping sera 7;8, and were negative for all other type and group-specific sera (Figure [1A](#F1){ref-type="fig"} and [1B](#F1){ref-type="fig"}). The conventional serological identification results were further confirmed by Western-blot assay. As shown in Figure [1C](#F1){ref-type="fig"}, the lipopolysaccharide (LPS) pattern of the newly constructed strain was identical to that of serotype X strain 014 (Panel a, Figure [1C](#F1){ref-type="fig"}) and that of serotype 1a strain 019 (Panel c, Figure [1C](#F1){ref-type="fig"}), when probed by group specific sera 7;8 and type specific sera I respectively. Since the original serotype Y strain and its SfI convertant 1a strain can agglutinate with grouping sera 3;4, we also tested whether this antigen is detectable in serotype 1 d. The LPS of the new serotype was not recognized by the grouping sera 3;4 (Panel b, Figure [1C](#F1){ref-type="fig"}). Additionally, serotype-specific genes, *gtrX*for phage SfX and *gtrI*for phage SfI, were detected from these new strains by PCR and sequencing of the PCR products.

![**Construction of a novel serotype, 1 d, of *S. flexneri*with serotype-converting bacteriophages SfX and SfI**. **(A**) Illustration of construction road map of *S. flexneri*036_1d strain from a serotype Y strain 036, by sequential infection of phages SfX and SfI. (**B**) Serological identification of *S. flexneri*036_1d as serotype 1 d with agglutination test using monovalent diagnostic sera. The constructed strain *S. flexneri*036_1d agglutinated with both of typing sera I and grouping sera7;8. (**C**) Serological identification of *S. flexneri*036_1d by Western-blot assay. The LPS extracted from the tested strains was separated by SDS-PAGE and hybridized with monovalent grouping sera 7;8 (**a**) and 3;4 (**b**), and typing sera I (**c**), respectively. LPS of serotype X strain 014 and serotype 1a strain 019 were used as positive controls for group specific antigen 7;8 and type specific antigen I. After strain name in brackets is the serotype of the strain.](1471-2180-11-269-1){#F1}

*S. flexneri*serotype 1 has three known subtypes, 1a, 1b and 1c, the agglutination patterns of which are defined by a combination of typing and grouping sera, namely typing sera I and grouping sera 3;4 (Y-5) for 1a, typing sera I and grouping sera 6 for 1b, *S. flexneri*group antigen specific MASF B and provisional specific monoclonal antibody MASF1c for 1c \[[@B17]\] (Table [1](#T1){ref-type="table"}). Since the newly constructed serotype agglutinates with typing sera I, but showed a different serological pattern from all known serotype 1 subtypes (Table [1](#T1){ref-type="table"}), we named this new serotype 1 d.

In order to determine whether such serotype-converting events could occur in nature, we randomly selected 24 *S. flexneri*serotype X strains in our collection, and infected them with serotype-converting phage SfI. All 24 strains tested were successfully converted to serotype 1 d.

We have no good explanation why serotype 1a strain 036_1a, constructed from 036 by infection with SfI, could not be further infected by SfX. We randomly selected 17 *S. flexneri*1a isolates from our collection for infection by SfX but found that none of them could be infected by SfX. Clearly, the SfI can infect the strains carrying serotype-converting phage SfX, but not vice versa, likely due to phage immunity from modified O-antigen receptors \[[@B20]\].

Interestingly, a recent study reported *S. flexneri*strains with identical serological characteristics to the novel serotype 1 d created in this study \[[@B21]\]. Four strains were designated as untypeable serotype I: (7;8) among 467 *S. flexneri*isolates collected in a passive surveillance project from Henan, China in 2006 \[[@B21]\]. Thus it seems that this novel serotype has already appeared in natural infections. Although serotype 1 d represented less than 1% of the isolates, it would be important to monitor this new serotype epidemiologically, considering that novel *S. flexneri*serotypes such as 1c and Xv achieved its dominance among the *S. flexneri*serotypes in a very short time frame \[[@B5],[@B16],[@B17]\]

SfI and SfX integrated in tandem into the same site of host chromosome
----------------------------------------------------------------------

It has been observed that the serotype-converting phages, except for Sf6, usually integrate into the *tRNA-thrW*gene of the host chromosome, which is adjacent to *proA*upstream \[[@B15]\]. However, the gene downstream the integrated phage have not been consistently identified \[[@B6],[@B7]\]. Genomic analysis of *S. flexneri*serotype 2a strain 301 (NC_004337), 2457 T (NC_004741) and serotype Xv strain 2002017 (CP001383) showed that the serotype-converting phages were all integrated upstream of host gene *yaiC*. Thus cross-bridging PCR analyses of *S. flexneri*036, 036_X, and 036_1d across the *proA-yaiC*region were conducted using a series of primers and found that both phages SfX and SfI were integrated into the *tRNA-thrW*site, which is immediately downstream of gene *proA*, and upstream of gene *yaiC*(Figure [2](#F2){ref-type="fig"}). The phage SfI was found to be integrated immediately upstream of SfX genome, with an *att*site at both ends (Figure [2](#F2){ref-type="fig"}). By comparing the joining sequences between the serotype-converting phage genomes, we found that the phage SfI was integrated at the *attL*site of phage SfX (see Additional file [1](#S1){ref-type="supplementary-material"}). The integration site for the 24 serotype X isolates converted by SfI was also found to be the same site and thus it appears that the integration is very site specific.

![**Genetic organization of prophage genomes of SfX and/or SfI in *S. flexneri*036_X and 036_1d**. The prophage genomes of SfX and/or SfI are highlighted in yellow and pink respectively. The conserved genes of the host strain were shown in different colors: *proA*, gray; *yaiC*, yellow; IS600 ORF1 and ORF2, brown; IS629 ORF1 and ORF2, orange; the putative integrase gene (*int*), white. The integration sites *attB*, *attL*and *attR*are indicated in thick line. After strain name in brackets is the serotype of the strain.](1471-2180-11-269-2){#F2}

Conclusions
===========

A novel serotype 1 d was constructed by sequentially infecting a serotype Y strain of *S. flexneri*with phage SfX and SfI, or by infecting clinical serotype X isolates with SfI. These results indicate that serotype conversion with phages SfI and SfX could occur in nature. However, the observation that the order of infection by the 2 phages affects convertibility of a strain indicates that serotype conversion is not only determined by the modification specific genes but also constrained by the properties of the serotype-converting phages. Our findings provide possible mechanisms how new serotypes of *S. flexneri*could emerge in nature.

Methods
=======

Bacterial strains and phages
----------------------------

*S. flexneri*strains and serotype-converting bacteriophages used in this study were listed in Table [2](#T2){ref-type="table"}. *S. flexneri*strain 036 (serotype Y) was used as host for phage infection and large propagation. *S. flexneri*strains 014 (serotype X) and 019 (serotype 1a) were used as positive controls in the serological assays for group specific antigen 7;8 and type specific antigen I respectively. Twenty four *S. flexneri*serotype X and 17 of *S. flexneri*serotype 1a strains isolated from patients and stored at National Institute for Communicable Disease Control and Prevention, China CDC (ICDC) were used for infection with serotype-converting phages SfI and SfX respectively.

###### 

Strains and serotype-converting bacteriophages used in this study

  Strains or phages      Relevant characteristic                               Reference or source
  ---------------------- ----------------------------------------------------- ---------------------
  *S. flexneri*strains                                                         
                                                                               
  036                    Serotype Y                                            ICDC
                                                                               
  014                    Serotype X                                            ICDC
                                                                               
  019                    Serotype 1a                                           ICDC
                                                                               
  036_1a                 036 infected by SfI, serotype 1a                      This study
                                                                               
  036_X                  036 infected by SfX, serotype X                       This study
                                                                               
  036_1d                 036 infected by SfI and SfX, serotype 1d              This study
                                                                               
  Phages                                                                       
                                                                               
  SfI                    Phage SfI, induced from *S. flexneri*strain 019       This study
                                                                               
  SfX                    Phage SfX, induced from *S. flexneri*strain 2002017   This study

ICDC, National Institute for Communicable Disease Control and Prevention, China CDC

Serotype-converting bacteriophages SfI and SfX were induced from *S. flexneri*serotype 1a strain 019 and serotype Xv strain 2002017 respectively, following the methods described by Mavris et al. \[[@B12]\].

Phage infection and lysogen isolation
-------------------------------------

We used the procedures described for lambda phage (Φλ) for phage infection \[[@B22]\]. *S. flexneri*cells were inoculated into LB broth and incubated for 3 h at 37°C with aeration. Cells were harvested by centrifugation at 4000 rpm and the cell density was adjusted to 2.0 OD (A~595\ nm~) with MgSO~4~buffer (10 mmol/L). A proportion of cells (200 μl) were infected with purified phages with phage to bacterial cell ratio of about 1:1000 and incubated for 20 min at 37°C. The infected cells were mixed with 3 ml semisolid agar (Luria Broth (LB) with 0.7% agar) and immediately spread on LB solid agar plates. After incubation at 37°C for 20 h, the lysogens were detected from turbid single colonies.

Slide agglutination and LPS analysis
------------------------------------

Serological identification was performed using two commercial slide agglutination serotyping kits: monovalent anti-sera (Denka Seiken, Japan) and monoclonal antibody reagents (Reagensia AB, Sweden) according to manufacturer\'s instructions. The new serotype was further confirmed by Western-blot assay. Briefly, LPS was prepared using the method of Hitchcock & Brown \[[@B23]\] and transferred onto a PVDF membrane in a Tris/glycine/methanol buffer. The membrane was blocked with phosphate buffered saline (PBS) containing 5% (w/v) skimmed milk and 0.05% Tween-20 and then incubated with serotype X-specific monovalent grouping sera 7;8 (Denka Seiken, Japan), serotype 1a-specific monovalent typing sera I (Denka Seiken, Japan), or monovalent grouping sera 3;4 (Denka Seiken, Japan). The membrane was then washed with 1 × PBS containing 0.05% Tween-20, and incubated with a secondary anti-rabbit antibody labeled with the fluorescent IRDye™ 800 (Rockland). Fluorescence was detected using an Odyssey Infrared Imaging System (LI-COR).

Identification of the integration site and orientation of SfX and SfI
---------------------------------------------------------------------

Based on previous studies showing that the integration site of serotyping-conversion bacteriophages is conserved \[[@B15]\], a series of primers were designed that were located in genes *proA*, *yaiC*, *gtrI*, *gtrX*, *intI*and *intX*across the presumptive integration region to determine the site and order of integration using PCR: *proA*-F, ACAAAGCGAAATCATCCTCAA; *intI*-R, AGTGTTACAGGAAATGGGAGGC. *gtrI*-F, ATTGAACGCCTCCTTGCTATGC; *intX*-R, TACGGTGGCTGCGTGAGAA. *gtrX*-F, TACCTTGACCCGTTTCCG; and *yaiC*-R, GCAGGAAACCACCATCAACACC. PCR products were sequenced commercially to identify the integration site precisely.
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Supplementary Material
======================

###### Additional file 1

**Supplementary figure**. DNA sequences of integration sites in 036, 036_X and 036_1d, and bacteriophages SfI and SfX. Sequences obtained by PCR and sequencing of junction regions using a series of primers across the integration site as described in the text. (A) *attB*in strain 036. (B) *attP*in phage SfI. (C) *attP*in phage SfX. (D) *attL*in strain 036_X. (E) *attR*in 036_X and 036_1d. (F) Sequence between phage SfI and SfX in strain 036_1d. Sequences in box are conserved DNA regions between genes; Underlined sequences are *tRNA-thrW*; Sequences in blue are *att*core sequence; Conserved genes flanking a given integration site are shaded and their transcription orientation is marked by an arrow.
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